Antitope to Present at Visiongain Monoclonal Antibodies conference, London, UK, 25 March 2009

Dr. Matthew Baker, Chief Scientific Officer of Antitope, will be giving a presentation entitled "Novel Antibodies for Breast and Prostate Cancer " at this year's Visiongain Monoclonal Antibodies conference in London.

The presentation will discuss the concept of therapeutic antibodies without helper T cell epitopes and further describe the application of such technologies for generating non-immunogenic therapies in oncology.

For more information, visit the conference website http://www.visiongain.com/Conference.aspx?cid=160